Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling
Gallob, F.; Lechner, S.; Tuckova, D.; Tyshchenko, Y.; Drpic, D.; Hajek, J.; Englmaier, L.; Delawska, K.; Unterlass, M.; Araujo, M.; Winter, G. E.; Hrouzek, P.; Villunger, A. E.
Show abstract
Natural products are a rich source of bioactive molecules that have served both as templates for drug discovery and as tools to uncover fundamental biological processes. While characterizing the pro-apoptotic activity of the cyanobacterial metabolite Nostatin A, we identified vacuolar-type H-ATPase (V-ATPase) as its molecular target and uncovered an unexpected signalling response preceding cell death initiation. V-ATPase inhibition rapidly activates the integrated stress response (ISR) through engagement of the GCN1/GCN2 kinase module, indicative of ribosomal collisions and translational shutdown. This response is conserved across established V-ATPase inhibitors, including bafilomycin A1, but not with compounds disrupting lysosomal function by other means. Mechanistically, V-ATPase inhibition depletes the pro-survival protein MCL-1 resulting in BAX/BAK-dependent mitochondrial apoptosis. Loss of MCL-1 creates a vulnerability that renders cells dependent on co-expressed BCL-2 family proteins, enabling potent synergy with the BH3 mimetics ABT-737 or venetoclax. Taken together, our results reveal a therapeutically exploitable vulnerability in V-ATPase-reliant or MCL-1 dependent cancers.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Endogenous formaldehyde scavenges cellular glutathione resulting in cytotoxic redox disruption 97%
- GAK and PRKCD are positive regulators of PRKN-independent mitophagy 97%
- CDK4 inactivation balances resistance to apoptosis with heightened metabolic sensitivity in triple negative breast cancer cells 97%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Alternative splice variants of the mitochondrial fission protein DNM1L/Drp1 regulate mitochondrial dynamics and cell fate in ovarian cancer. 96%
- IRE1 RNase controls CD95-mediated cell death 96%
- Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca2+-dependent death of cancer cells 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.